Comparative Study of OPC-1085EL Ophthalmic Solution to Latanoprost Ophthalmic Solution 0.005% in Subjects with Primary Open-Angle Glaucoma or Ocular Hypertension (Phase 3 study)

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080222437

Enrollment

220

Registered

2014-03-26

Start date

2014-03-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma or ocular hypertension

Interventions

investigational material(s) Generic name etc : OPC-1085EL ophthalmic solution INN of investigational material : Therapeutic category code : 131 Agents for ophthalmic use Dosage and Administration for

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects with bilateral primary open-angle glaucoma or ocular hypertension

Exclusion criteria

Exclusion criteria: Subjects with ocular conditions as defined by the protocol

Design outcomes

Primary

Measure	Time frame
Intraocular pressure	—

Secondary

Measure	Time frame
Efficacy: Intraocular pressure Safety	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026